Annual report pursuant to Section 13 and 15(d)

Income Tax Expense (Tables)

v3.10.0.1
Income Tax Expense (Tables)
12 Months Ended
Dec. 31, 2017
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Benefit (Provision)

The Company’s income tax (benefit)/provision is as follows:

 

    Years Ended December 31,  
    2017     2016  
    (restated)        
Current   $ -     $ -  
Deferred     (6,003,000 )   $ (751,000 )
Change in Valuation Allowance     6,003,000     $ 751,000  
Income Tax Benefit   $ -     $ -  

Schedule of Reconciliation of Income Taxes using Statutory U.S. Income Tax Rate and Benefit from Income Taxes

The reconciliation of income taxes using the statutory U.S. income tax rate and the benefit from income taxes for the years ended December 31, 2017 and 2016 are as follows:

 

    Years Ended December 31,  
    2017     2016  
    (restated)        
Statutory U.S. Federal Income Tax Rate     (35.0 %)     (35.0 %)
New Jersey State income taxes, net of U.S.                
Federal tax effect     (6.0 %)     (6.0 %)
Tax rate change     122.0 %     0.0 %
Change in Valuation Allowance     (81.0 )%     41.0 %
Net     0.0 %     0.0 %

Schedule of Deferred Tax Assets and Related Valuation Allowances

The principle components of the deferred tax assets and related valuation allowances as of December 31, 2017 and 2016 are as follows:

 

    Years Ended December 31,  
    2017     2016  
    (restated)        
Reserves and other   $ 718,000     $ 865,000  
Net operating loss carry-forwards     15,762,000       21,618,000  
Valuation Allowance     (16,480,000 )     (22,483,000 )
Net   $ -     $ -